- Approval Id
- 0f7a20f3d6ec73ea
- Drug Name
- HAEMODIALYSIS CONCENTRATE NKFS-01 (ACID) FOR BICARBONATE DIALYSIS
- Product Name
- HAEMODIALYSIS CONCENTRATE NKFS-01 (ACID) FOR BICARBONATE DIALYSIS
- Approval Number
- SIN09474P
- Approval Date
- 1997-08-21
- Registrant
- B. BRAUN SINGAPORE PTE LTD
- Licence Holder
- B. BRAUN SINGAPORE PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- General Sale List
- Dosage Form
- SOLUTION
- Dosage
- **Dosage**
Unless otherwise directed, mix 1.000 l NKFS-0x (acid concentrate) and 1.225 l Sodium Bicarbonate 8.4% with 32.775 l water of suitable quality. Please refer to the product label of the acid concentrate used for details of the mixing ratio.
**Mode and duration of administration**
For extracorporeal bicarbonate haemodialysis or bicarbonate haemodiafiltration.
The duration of administration must be determined on an individual basis.
- Route Of Administration
- HEMODIALYSIS
- Indication Info
- **Indications**
The indications below apply exclusively to the ready-to-use bicarbonate haemodialysis solution prepared from acid concentrate and bicarbonate concentrate following the specified dilution procedure:
- Acute renal failure
- Chronic renal failure
- Hyperhydration
- Intoxications
- Compensation of acid-base and electrolyte balances
- Adjustment of the blood / plasma / body temperature
- Contraindications
- **Contraindications**
- Hyperkalaemia with the use of a potassium-containing acidic bicarbonate haemodialysis concentrate
- Hypokalaemia with the use of a potassium-free acidic bicarbonate haemodialysis concentrate
- Intractable coagulopathy
In patients with unstable circulation and/or unstable blood pressure, a different extracorporeal method of treatment may be indicated.
- Atc Code
- B05ZA
- Atc Item Name
- 血液透析
- Pharma Manufacturer Name
- B. Braun Singapore Pte Ltd.
- Company Detail Path
- /organization/b-braun-singapore-pte-ltd
